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Abstract: 
Lysyl tRNA synthetases facilitate amino acylation and play a crucial role in the essential cellular process of translation. 
They are grouped into two distinct classes (class I and class II). Class I lysyl tRNA synthetase is considered as a drug 
target for syphilis caused by Treponema pallidum. Comparative genome analysis shows the absence of its sequence 
homolog in eukaryotes. The structure of class I lysyl tRNA synthetase from Treponema pallidum is unknown and the 
difficulties in the in vitro culturing of Treponema makes it non-trivial. We used the structural template of class I lysyl 
tRNA synthetase from the archaea Pyrococcus horikoshii for modeling the Treponema pallidum lysyl tRNA synthetase 
structure. Thus, we propose the usefulness of the modeled class I lysyl tRNA synthetase for the design of suitable 
inhibitors towards the treatment of syphilis. 
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Background: 
Syphilis is a STD (sexually transmitted disease) 
caused by Treponema pallidum. The understanding of 
host-pathogen interactions remains unclear due to 
difficulty in culturing the organism in vitro. Syphilis is 
an exclusive human pathogen and its pathogenesis 
from animal study provides limited inference. [1] The 
availability of the complete genome sequence of 
Treponema pallidum provides ample opportunities for 
the computational analysis towards the identification 
of potential drug targets.  
 
Lysyl tRNAs are essential for protein biosynthesis by 
ribosomal mRNA translation. They are synthesized by 
lysyl tRNA synthetases (a group of enzymes of two 
unrelated protein families, namely, class I and II). 
Known lysyl tRNA synthetases are class II in 
bacteria/eukaryotes and class I in archaea. A recent 
genomic analysis showed the presence of the archaeal 
type class-I lysyl tRNA synthetase  in Treponema 
pallidum and Borellia species.  [2] The difference 
between the lysyl tRNA synthetases of spirochetes and 
their hosts is for potential exploitation towards the 
development of anti-spirochete therapeutics. The X-
ray crystal structure of class-I lysyl tRNA synthetase 
from the archaea Pyrococcus horikoshii is known. [3] 
Here, we use this structure as a template for the 
modeling of class-I lysyl tRNA synthetase from 
Treponema pallidum. We discuss the modeled 
structure as a potential drug target for syphilis caused 
by Treponema pallidum.  
 
 
Methodology: 
Lysyl tRNA synthetase sequence: 
The protein sequence for class I lysyl tRNA synthetase 
of Treponema pallidum (O83650) was obtained from 
the SWISS PROT database.  
 
Template selection: 
The sequence was then searched against PDB (protein 
databank) protein sequences [4] using BLASTP [5] 
and a potential template structure (PDB-ID: 1IRX) 
was identified at an E-value (expect value) cut-off of 
3e-110.  
 
Molecular modeling: 
An ensemble of 20 models for the class I lysyl tRNA 
synthetase from Treponema pallidum was generated 
using MODELLER by satisfaction of spatial restraints. 
[6]  
 
Model evaluation: 
The backbone of 20 models were overlapped well with 
the template structure and the most reliable structure 
was chosen based on least objective function value 
and stereo chemical quality of the models using the 
PROCHECK analysis. [7] In addition, the 
superimposition was also performed using the 
SUPERPOSE command in MODELLER and the 
RMSD (root mean square deviation) between 
predicted model and template is 0.7 angstrom. The 
predicted model quality assessment was checked using 
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angles. The analysis shows that 92.5 % of residues are 
found to be in the allowed region of the plot which is 
more than the average cut-off of 90% in most reliable 
models.  [8]  The bond lengths and bond angles 
analyses of the modeled structure satisfies the small 
molecule experimental data described by Kabsch et 
al.,. [9] 
________________________________________________________________________________________________ 
 
Utility of the study: 
Here, we illustrate the potential use of molecular 
models towards the likely design of inhibitors for the 
class I tRNA synthetase enzyme from Treponema 
pallidum. The study is highly pertinent where the 
difficulty of solving the structure of the protein is high 
(culturing of Treponema pallidum is difficult in this 
case). 
 
Conclusion: 
A molecular model of the class I lysyl tRNA 
synthetase from Treponema pallidum is documented 
in this study. The model is believed to provide 
valuable insights towards the design of an inhibitor for 
class I lysyl tRNA synthetase for the treatment of 
syphilis. However, further computational docking and 
high throughput screening experiments are required in 
detail for extracting more useful information.  
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